Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,904 | -31,333 | -23,260 | -13,630 | -5,948 |
| Accounts payable and accrued liabilities | 436 | 816 | 1,603 | -134 | 749 |
| Other Working Capital | -724 | -1,300 | -1,000 | -2,719 | -915 |
| Other Operating Activity | 1,586 | 5,228 | 2,684 | 2,890 | 129 |
| Operating Cash Flow | $-8,606 | $-26,589 | $-19,973 | $-13,593 | $-5,985 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 617 | 616 | 414 | 459 |
| Other Financing Activity | 0 | 0 | 0 | 105 | 0 |
| Financing Cash Flow | $N/A | $617 | $616 | $519 | $459 |
| Beginning Cash Position | 90,765 | 116,737 | 116,737 | 116,737 | 116,737 |
| End Cash Position | 82,159 | 90,765 | 97,380 | 103,663 | 111,211 |
| Net Cash Flow | $-8,606 | $-25,972 | $-19,357 | $-13,074 | $-5,526 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,606 | -26,589 | -19,973 | -13,593 | -5,985 |
| Free Cash Flow | -8,606 | -26,589 | -19,973 | -13,593 | -5,985 |